TrialScope debuts website platform with patient engagement capabilities

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/kwangmoozaa)
(Image: Getty/kwangmoozaa)

Related tags: website, Patient centricity, Patient recruitment, Transparency, trial transparency

TrialScope has launched clinical trial transparency service and health literacy management solution.

The clinical trial transparency service​ (CTTS) will allow sponsors to engage with patients, health care professionals, and researchers, through a public wesbite that will act as a space for further involvement between community members and sponsors.

The CTTS is immediately available to sponsors and can be integrated with the company’s other offerings. In an age where trial transparency is being repeatedly called for, sponsors can now demonstrate relevance and compliance through the website. Sponsors can include documents, forms, regulations, eligibility requirements, even trial restrictions on the site, according to the company

Francine Lane, VP of global transparency told us that with transparency, the medical community, including patients and caregivers, can easily find trials that are applicable to them.

“Being more transparent allows sponsors to build trust with the public, which can lead to higher levels of recruitment and engagement in clinical trials and, ultimately, to the success and viability of the trial,”​ said Lane.

Through the new CTTS, patients will be able to find clinical trials through a location-based search function and sponsor websites. The service also connects patients to others within the clinical trial sphere through social media outlets, including Facebook, Twitter, and email.

Additionally, the sponsor’s website will be automatically updated with information submitted to to reduce redundancy and improve accuracy. This will be done as part of the CTTS service that allows sponsors to share trial data, trial literacy, and trial recruitment for patient education and retention.

TrialScope has partnered with patients, advocacy groups, and communication experts to provide an interface that delivers easy-to-understand trial information. This aspect will provide literacy in an aim to make trials more engaging and patient-centric, according to the company.

Lane put it ever so simply, “Patients and caregivers also deserve to understand what they're reading.”

TrialScope debuted the service with three customers that are cited by the company to be of the top 20 pharmaceutical companies in the world.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us


View more